Morepen Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

21 Sep 2018 | 03:59 PM

25.80
-1.15 (-4.27%)

  • Outperforms Index

    47.01%

    Return (1Y)

    Beaten S&P BSE Healthcare by 36.87%

  • More Volatile

    4.11%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 3.06%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

44

44.35

16

15.70

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Morepen Laboratories Ltd has increased by 61.67% since past 3 Months

  • FII shareholding in Morepen Laboratories Ltd has increased by 14030% since past 1 Year

Loading...